Corticosteroids, Plasmapheresis, Argatroban, Rituximab, and Sirolimus Provided Clinical Benefit for Catastrophic Antiphospholipid Syndrome in a Patient with a History of Heparin-Induced Thrombocytopenia

We report a patient with catastrophic antiphospholipid syndrome who had significant improvement after corticosteroids, plasmapheresis, argatroban, rituximab, and sirolimus. Argatroban was used instead of heparin due to a history of heparin-induced thrombocytopenia.

Detalles Bibliográficos
Autores principales: Hasan, Haytham, Surjancev, Ivana, Arnason, Jon A., Garg, Shivani, Rose, William Nicholas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9935868/
https://www.ncbi.nlm.nih.gov/pubmed/36816449
http://dx.doi.org/10.1155/2023/3226278
_version_ 1784890107348647936
author Hasan, Haytham
Surjancev, Ivana
Arnason, Jon A.
Garg, Shivani
Rose, William Nicholas
author_facet Hasan, Haytham
Surjancev, Ivana
Arnason, Jon A.
Garg, Shivani
Rose, William Nicholas
author_sort Hasan, Haytham
collection PubMed
description We report a patient with catastrophic antiphospholipid syndrome who had significant improvement after corticosteroids, plasmapheresis, argatroban, rituximab, and sirolimus. Argatroban was used instead of heparin due to a history of heparin-induced thrombocytopenia.
format Online
Article
Text
id pubmed-9935868
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-99358682023-02-18 Corticosteroids, Plasmapheresis, Argatroban, Rituximab, and Sirolimus Provided Clinical Benefit for Catastrophic Antiphospholipid Syndrome in a Patient with a History of Heparin-Induced Thrombocytopenia Hasan, Haytham Surjancev, Ivana Arnason, Jon A. Garg, Shivani Rose, William Nicholas Case Rep Rheumatol Case Report We report a patient with catastrophic antiphospholipid syndrome who had significant improvement after corticosteroids, plasmapheresis, argatroban, rituximab, and sirolimus. Argatroban was used instead of heparin due to a history of heparin-induced thrombocytopenia. Hindawi 2023-02-09 /pmc/articles/PMC9935868/ /pubmed/36816449 http://dx.doi.org/10.1155/2023/3226278 Text en Copyright © 2023 Haytham Hasan et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Hasan, Haytham
Surjancev, Ivana
Arnason, Jon A.
Garg, Shivani
Rose, William Nicholas
Corticosteroids, Plasmapheresis, Argatroban, Rituximab, and Sirolimus Provided Clinical Benefit for Catastrophic Antiphospholipid Syndrome in a Patient with a History of Heparin-Induced Thrombocytopenia
title Corticosteroids, Plasmapheresis, Argatroban, Rituximab, and Sirolimus Provided Clinical Benefit for Catastrophic Antiphospholipid Syndrome in a Patient with a History of Heparin-Induced Thrombocytopenia
title_full Corticosteroids, Plasmapheresis, Argatroban, Rituximab, and Sirolimus Provided Clinical Benefit for Catastrophic Antiphospholipid Syndrome in a Patient with a History of Heparin-Induced Thrombocytopenia
title_fullStr Corticosteroids, Plasmapheresis, Argatroban, Rituximab, and Sirolimus Provided Clinical Benefit for Catastrophic Antiphospholipid Syndrome in a Patient with a History of Heparin-Induced Thrombocytopenia
title_full_unstemmed Corticosteroids, Plasmapheresis, Argatroban, Rituximab, and Sirolimus Provided Clinical Benefit for Catastrophic Antiphospholipid Syndrome in a Patient with a History of Heparin-Induced Thrombocytopenia
title_short Corticosteroids, Plasmapheresis, Argatroban, Rituximab, and Sirolimus Provided Clinical Benefit for Catastrophic Antiphospholipid Syndrome in a Patient with a History of Heparin-Induced Thrombocytopenia
title_sort corticosteroids, plasmapheresis, argatroban, rituximab, and sirolimus provided clinical benefit for catastrophic antiphospholipid syndrome in a patient with a history of heparin-induced thrombocytopenia
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9935868/
https://www.ncbi.nlm.nih.gov/pubmed/36816449
http://dx.doi.org/10.1155/2023/3226278
work_keys_str_mv AT hasanhaytham corticosteroidsplasmapheresisargatrobanrituximabandsirolimusprovidedclinicalbenefitforcatastrophicantiphospholipidsyndromeinapatientwithahistoryofheparininducedthrombocytopenia
AT surjancevivana corticosteroidsplasmapheresisargatrobanrituximabandsirolimusprovidedclinicalbenefitforcatastrophicantiphospholipidsyndromeinapatientwithahistoryofheparininducedthrombocytopenia
AT arnasonjona corticosteroidsplasmapheresisargatrobanrituximabandsirolimusprovidedclinicalbenefitforcatastrophicantiphospholipidsyndromeinapatientwithahistoryofheparininducedthrombocytopenia
AT gargshivani corticosteroidsplasmapheresisargatrobanrituximabandsirolimusprovidedclinicalbenefitforcatastrophicantiphospholipidsyndromeinapatientwithahistoryofheparininducedthrombocytopenia
AT rosewilliamnicholas corticosteroidsplasmapheresisargatrobanrituximabandsirolimusprovidedclinicalbenefitforcatastrophicantiphospholipidsyndromeinapatientwithahistoryofheparininducedthrombocytopenia

Ejemplares similares